BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

May 22, 2002

View Archived Issues

Avant's cholera vaccine enters phase II study

Read More

Targeted Genetics completes enrollment in phase II study of tgAAVCF in cystic fibrosis

Read More

SC-51 inhibits exhaled breath NO in normal and asthmatic subjects

Read More

Andolast pretreatment reduces AMP-induced airways hyperresponsiveness

Read More

Novel antiobesity agents presented by Sanofi-Synthelabo

Read More

Trypsin-like serine protease inhibitors patented by BioCryst

Read More

New cholesterol-lowering agents in development at Ilex Oncology

Read More

VEGF antagonists identified at Ark Therapeutics

Read More

Pfizer claims endothelin ETA antagonists for cardiovascular disorders

Read More

Merck discovers new antidiabetic PPAR agonists

Read More

Indoles as tissue-selective estrogen receptor modulators and their use

Read More

New LTB4 antagonists patented by Boehringer Ingelheim

Read More

Fidarestat reverses cellular responses to high glucose concentrations

Read More

Statins may be effective for the treatment of certain diabetic complications

Read More

Morphological and functional improvement seen in Ro-444753-treated rats with emphysema

Read More

Novel PDE4 inhibitor Ono-6126 with potential in asthma, low emetogenic liability

Read More

Selective inhibition of eosinophil adhesion to VCAM-1 demonstrated for new VLA-4 inhibitor

Read More

Neutrophil infiltration directly involved in the development of airways hyperresponsiveness

Read More

Caspase inhibitor improves liver function tests with good safety in first clinical trial

Read More

Studies using SB-203580 demonstrate involvement of p38 kinase in colon cancer

Read More

GLP-2 analogue provides clinical, functional and structural improvement in SBS patients

Read More

Cell Pathways to initiate early experience program for Gelclair

Read More

Neutrophil elastase inhibitor reported to have beneficial effects in guinea pig model of emphysema

Read More

Novartis launches TARGET trial of Prexige in arthritis

Read More

FDA approves Zoloft for premenstrual dysphoric disorder

Read More

Phase II enrollment completed for dalbavancin in complicated skin and soft tissue infections

Read More

Celltech and Amgen to research and develop novel osteoporosis treatments

Read More

Orphan Medical submits complete response to Xyrem approvable letter

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 13, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • Illustration of a motor neuron

    Keros reports beneficial effects of RKER-065 in ALS model

    BioWorld Science
    Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D

    BioWorld Science
    Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing